Applied Biomolecular Technologies
Private Company
Total funding raised: $6.5M
Overview
Applied Biomolecular Technologies is a specialized contract development and commercialization services firm for the biologics and diagnostics sectors. Leveraging a highly credentialed team of PhD scientists, ABT offers a full suite of services from problem identification and technology development to IP strategy and commercialization pathway definition. Its business model is centered on being a collaborative, outsourced partner for companies seeking to commercialize protein-based therapeutics and diagnostics, operating primarily in a pre-revenue or project-based revenue stage as a private entity.
Technology Platform
Integrated service model leveraging deep expertise in protein biochemistry, genetic engineering, and commercialization strategy to act as a virtual development team for clients.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
ABT competes in the contract research and development (CRD) space, facing competition from large global CROs (e.g., LabCorp, IQVIA), niche technical specialists, and the in-house teams of potential clients. Its differentiation is a high-touch, collaborative model with deep PhD-level expertise in protein science.